Amyvid

Generic name: Florbetapir F 18
Drug class: Diagnostic radiopharmaceuticals

Usage of Amyvid

Amyvid belongs to a group of drugs called diagnostic radiopharmaceuticals. Amyvid allows images of specific organs in the body to be detected by a PET (Positron Emission Tomography) scan.

Amyvid is used together with a PET scan to detect the amount of plaque in the brain. Plaque is a build-up of certain proteins and diseased nerve cells that is often found in the brain of a person who has signs of Alzheimer's disease or other causes of dementia.

Amyvid is supplied in multiple doses vials enclosed in a shielded container to minimize external radiation exposure.

Amyvid side effects

Get emergency medical help if you have signs of an allergic reaction to Amyvid: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Common Amyvid side effects may include:

  • pain, bruising, swelling, or irritation where the medicine was injected;
  • headache;
  • joint or muscle pain;
  • increased blood pressure;
  • nausea; or
  • feeling tired.
  • This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

    Before taking Amyvid

    Tell your doctor about all of your medical conditions.

    Tell your doctor if you are pregnant. There is no information available on the use of Amyvid in pregnant women. All radiopharmaceuticals, including Amyvid, have a potential to cause harm to the unborn baby depending on the stage of pregnancy and the size of the florbetapir F 18 dose.

    Do not breastfeed within 24 hours after receiving Amyvid. If you use a breast pump during this time, throw out the milk and do not feed it to your baby.

    Relate drugs

    How to use Amyvid

    Usual Adult Dose for Positron Emission Tomography Imaging:

    370 MBq (10 mCi), maximum 50 microgram mass dose, intravenously as a single bolus in a total volume of 10 mL or less Comments: The injection should be followed with an intravenous flush of 0.9% sterile sodium chloride. Use: PET imaging of the brain to estimate beta-amyloid neuritic plaque density in adult patients with cognitive impairment who are being evaluated for Alzheimer's Disease (AD) and other causes of cognitive decline.

    Warnings

    Receiving a radioactive agent such as Amyvid may increase your long-term risk of developing cancer. Talk with your doctor about your specific risk.

    To make sure you can safely receive Amyvid, tell your doctor about all of your medical conditions.

    Do not breast-feed within 24 hours after receiving Amyvid. If you use a breast pump during this time, throw out any milk you collect. Do not feed it to your baby. Receiving a radioactive agent such as Amyvid may increase your long-term risk of developing cancer. Talk with your doctor about your specific risk.

    What other drugs will affect Amyvid

    There may be other drugs that can interact with florbetapir F 18. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords